Ex parte A
17 USPQ2d 1716BPAI
AI-generated holding
A compound not specifically named in a reference is anticipated by a generic formula only if the classes of substituents are sufficiently limited or well delineated. Also, unexpected superior therapeutic activity against a class of bacteria can rebut prima facie obviousness even without evidence of effectiveness against all bacteria.
Generated summary for orientation only — not legal advice. Verify against the opinion.